75
Views
18
CrossRef citations to date
0
Altmetric
Brief Report

The role of microalbuminuria and insulin resistance as significant risk factors for white matter lesions in Japanese type 2 diabetic patients

, , , , , , , & show all
Pages 1561-1567 | Accepted 17 Mar 2008, Published online: 17 Apr 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Toshiya Katsumata, Tatsuo Otori, Yutaka Nishiyama, Seiji Okubo, Yasuhiro Nishiyama, Hiroshi Nagayama, Masayuki Ueda, Koichi Utsumi, Mineo Yamazaki, Yuichi Komaba, Ken-Ichiro Katsura & Yasuo Katayama. (2010) Correlation between insulin resistance and white matter lesions among non-diabetic patients with ischemic stroke. Neurological Research 32:7, pages 743-747.
Read now

Articles from other publishers (17)

Cun-Sheng Wei, Cai-Yun Yan, Xiao-Rong Yu, Lin Wang, Rui Zhang, Jun-Ying Jiang, Qi Dai, Jun-Rong Li & Xue Mei Chen. (2022) Association Between White Matter Hyperintensities and Chronic Kidney Disease: A Systematic Review and Meta-Analysis. Frontiers in Medicine 9.
Crossref
Min Zhou, Rongwen Li, Poornima Venkat, Yu Qian, Michael Chopp, Alex Zacharek, Julie Landschoot-Ward, Brianna Powell, Quan Jiang & Xu Cui. (2022) Post-Stroke Administration of L-4F Promotes Neurovascular and White Matter Remodeling in Type-2 Diabetic Stroke Mice. Frontiers in Neurology 13.
Crossref
Sergio Grosu, Roberto Lorbeer, Felix Hartmann, Susanne Rospleszcz, Fabian Bamberg, Christopher L Schlett, Franziska Galie, Sonja Selder, Sigrid Auweter, Margit Heier, Wolfgang Rathmann, Katharina Mueller-Peltzer, Karl-Heinz Ladwig, Annette Peters, Birgit B Ertl-Wagner & Sophia Stoecklein. (2021) White matter hyperintensity volume in pre-diabetes, diabetes and normoglycemia. BMJ Open Diabetes Research & Care 9:1, pages e002050.
Crossref
Jing Sun, Baofeng Xu, Xuejiao Zhang, Zhidong He, Ziwei Liu, Rui Liu & Guangxian Nan. (2020) The Mechanisms of Type 2 Diabetes-Related White Matter Intensities: A Review. Frontiers in Public Health 8.
Crossref
Xiaohui Wang, Rongwen Li, Alex Zacharek, Julie Landschoot-Ward, Michael Chopp, Jieli Chen & Xu Cui. (2019) ApoA-I Mimetic Peptide Reduces Vascular and White Matter Damage After Stroke in Type-2 Diabetic Mice. Frontiers in Neuroscience 13.
Crossref
Ruolan Huang & Xiaowu Chen. (2019) Increased Spot Urine Albumin-to-Creatinine Ratio and Stroke Incidence: A Systematic Review and Meta-Analysis. Journal of Stroke and Cerebrovascular Diseases 28:10, pages 104260.
Crossref
Junfeng LiuLoes Rutten-JacobsMing LiuHugh S. MarkusMatthew Traylor. (2018) Causal Impact of Type 2 Diabetes Mellitus on Cerebral Small Vessel Disease. Stroke 49:6, pages 1325-1331.
Crossref
Joshua I. Barzilay, Timothy M. Morgan, Anne M. Murray, R. Nick Bryan, Jeff D. Williamson, Adrian Schnall & Lenore J. Launer. (2016) Brain MRI Volume Findings in Diabetic Adults With Albuminuria: The ACCORD-MIND Study. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 71:6, pages 803-810.
Crossref
Yoshiaki Tamura & Atsushi Araki. (2015) Diabetes mellitus and white matter hyperintensity. Geriatrics & Gerontology International 15, pages 34-42.
Crossref
A. Del Bene, L. Ciolli, L. Borgheresi, A. Poggesi, D. Inzitari & L. Pantoni. (2015) Is type 2 diabetes related to leukoaraiosis? an updated review. Acta Neurologica Scandinavica 132:3, pages 147-155.
Crossref
Mariana Murea, Fang-Chi Hsu, Amanda J. Cox, Christina E. Hugenschmidt, Jianzhao Xu, Jeremy N. Adams, Laura M. Raffield, Christopher T. Whitlow, Joseph A. Maldjian, Donald W. Bowden & Barry I. Freedman. (2015) Structural and functional assessment of the brain in European Americans with mild-to-moderate kidney disease: Diabetes Heart Study-MIND. Nephrology Dialysis Transplantation 30:8, pages 1322-1329.
Crossref
Stephen D.J. Makin, F.A.B. Cook, Martin S. Dennis & Joanna M. Wardlaw. (2015) Cerebral Small Vessel Disease and Renal Function: Systematic Review and Meta-Analysis. Cerebrovascular Diseases 39:1, pages 39-52.
Crossref
Manon Brundel, L. Jaap Kappelle & Geert Jan Biessels. (2014) Brain imaging in type 2 diabetes. European Neuropsychopharmacology 24:12, pages 1967-1981.
Crossref
Yusuf Yilmaz, Fatih Eren, Oya Yonal, Ramazan Kurt, Bilge Aktas, Cigdem Ataizi Celikel, Osman Ozdogan, Nese Imeryuz, Cem Kalayci & Erol Avsar. (2010) Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease. European Journal of Clinical Investigation 40:10, pages 887-892.
Crossref
Futoshi Anan, Takayuki Masaki, Kimiko Jikumaru, Tetsu Iwao, Nobuoki Eshima, Tetsunori Saikawa & Hronobu Yoshimatsu. (2010) Hepatocyte growth factor is a significant risk factor for white matter lesions in Japanese type 2 diabetic patients. European Journal of Clinical Investigation 40:7, pages 585-590.
Crossref
Futoshi Anan, Takayuki Masaki, Tetsuji Shinohara, Kunio Yufu, Naohiko Takahashi, Mikiko Nakagawa, Nobuoki Eshima, Tetsunori Saikawa & Hironobu Yoshimatsu. (2009) White matter lesions are associated with the results of 123I-metaiodobenzylguanidine myocardial scintigraphy in type 2 diabetes mellitus patients. Metabolism 58:5, pages 696-703.
Crossref
Esther van den Berg, Yael D. Reijmer & Geert Jan Biessels. 2010. Diabetes and the Brain. Diabetes and the Brain 295 322 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.